Related Experiment Video
Updated: May 25, 2026
11:08
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Human immunodeficiency virus-associated malignancies: a therapeutic update
Antonello Malfitano1, Giuseppe Barbaro, Alessandro Perretti
1Department of Infectious Diseases, Unit of Infectious and Tropical Diseases, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Current HIV Research
|February 15, 2012
Summary
Highly active antiretroviral therapy (HAART) has shifted HIV-associated cancer trends, decreasing some tumors while increasing others. HIV patients now receive similar cancer treatments, but unique immune challenges remain.
Area of Science:
- Oncology
- Infectious Diseases
- Immunology
Background:
- Highly active antiretroviral therapy (HAART) has significantly altered the spectrum of HIV-associated malignancies.
- A decline in AIDS-defining cancers like primary CNS lymphoma contrasts with an increase in non-AIDS-defining tumors, likely due to increased survival in HIV-infected individuals.
Purpose of the Study:
- To analyze the evolving landscape of HIV-associated malignancies in the era of HAART.
- To discuss the implications of improved immune function and longer survival on cancer treatment approaches for HIV patients.
Main Methods:
- Review of epidemiological trends in HIV-associated cancers.
- Analysis of treatment advancements and their impact on patient outcomes.
- Discussion of challenges and future directions in managing HIV-related cancers.
Main Results:
- Significant reduction in certain AIDS-defining cancers.
- Increase in non-AIDS-defining malignancies.
- HIV patients are increasingly undergoing aggressive cancer treatments, including stem cell and liver transplants.
Conclusions:
- HIV-associated cancers present a unique oncological challenge despite patient assimilation with the general population.
- Future concerns include drug-drug interactions, biotherapy infections, and optimal timing of HAART initiation.
- Managing HIV-associated malignancies requires specialized approaches considering the unique immune status of HIV-infected individuals.
Related Concept Videos
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...